An overview of the
current data from PsoProtectMe

Current Data

We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary and include a limited number of participants, so should not be used to inform clinical decision making.

Click here to read our recently published scientific research paper detailing PsoProtect data.

A summary of this research can be found on the Psoriasis Association website here.

PsoProtectMe surveys completed

Summary data from PsoProtectMe’s first 3143 participants.

Participants per country (≥10 participants):

Country Participants Country Participants
Argentina 77 Norway 14
Australia 29 Panama 11
Brazil 15 Peru 14
Canada 44 Philippines 54
Chile 154 Poland 30
Denmark 50 Portugal 203
Hong Kong 18 Singapore 12
India 16 Spain 67
Ireland 45 Sweden 35
Italy 15 United Kingdom 1815
Japan 89 United States 184
Netherlands 17 Other (<10) 135

Average age: 47 years (range 3-91)

Average BMI: 26.75 kg/m2

Type of psoriasis: 2630 plaque psoriasis, 673 guttate psoriasis, 185 pustular psoriasis, 68 erythrodema


Smoking status:

Coexisting psoriatic arthritis:

Type of psoriasis treatment:

Psoriasis severity change during the pandemic:

Have you been diagnosed with or thought you had COVID-19?

Did you go to hospital A&E due to your COVID-19?

Did you stay in hospital due to your COVID-19?

Has your COVID-19 infection got better?